ASND

Ascendis Pharma A/S

Contracts

Total Value

Stock Metrics

5.5%

Short % Float

7.2d to cover · Moderate squeeze

1.0%

Inst % Float

10 holders · 2026-06-30

Massachusetts Fina

Top Holder

2.9% of float

62.1M sh

Public Float

13/100

Dilution Score

Low

Verified regulatory filings & proprietary analysis.

Dilution Risk

13/100

LOW

Inst: 1.03% · Top: Massachusetts Financial Services Co.

Biotech Analytics

Rare Endocrine

53.28

Squeeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk13

Clinical Trials100

Short Interest30